Application of polarity switching in the identification of the metabolites of RO9237
- 26 April 2007
- journal article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 21 (10) , 1661-1668
Abstract
Polarity switching mass spectrometry is an efficient way to collect structural data on drug metabolites. The value of this approach is illustrated with the in vitro metabolism of RO9237. Metabolites are identified by positive and negative electrospray ionization (ESI) full scan mass spectrometry, MS/MS and MS 3 using unlabelled and 14 C‐radiolabelled versions of the drug. Comparison of the relative detectability of these metabolites by +ESI and −ESI shows that neither ESI mode is universal. It is advantageous to screen for metabolites using both positive and negative ionization modes. This is especially true for phase II metabolism which tends to make molecules more polar and often more acidic. Identification of phase II metabolites also benefits greatly from MS 3 experiments because the conjugating groups typically are cleaved in MS/MS and information on the core structure is only obtained in MS 3 . A special case of phase II metabolism is the generation of glutathione (GSH) conjugates from reactive metabolites. The detection of GSH conjugates also benefits from generating both positive and negative ESI mass spectral data. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometryJournal of Mass Spectrometry, 2006
- Ultra‐performance liquid chromatography coupled to linear ion trap mass spectrometry for the identification of drug metabolites in biological samplesRapid Communications in Mass Spectrometry, 2006
- High‐throughput quantification for a drug mixture in rat plasma – a comparison of Ultra Performance™ liquid chromatography/tandem mass spectrometry with high‐performance liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2006
- In vivo metabolite detection and identification in drug discovery via LC‐MS/MS with data‐dependent scanning and postacquisition data miningJournal of Mass Spectrometry, 2005
- Simultaneous determination of paracetamol and dextropropoxyphene in human plasma by liquid chromatography/tandem mass spectrometry: application to clinical bioequivalence studiesRapid Communications in Mass Spectrometry, 2005
- Simultaneous determination of beta‐blocking agents and diuretics in doping analysis by liquid chromatography/mass spectrometry with scan‐to‐scan polarity switchingRapid Communications in Mass Spectrometry, 2004
- Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry dataRapid Communications in Mass Spectrometry, 2004
- The unanticipated loss of SO 2 from sulfonamides in collision‐induced dissociationRapid Communications in Mass Spectrometry, 2002
- High‐throughput cytochrome P450 (CYP) inhibition screening via a cassette probe‐dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1Rapid Communications in Mass Spectrometry, 2001
- Ion–neutral complexes in the unimolecular reactivity of organic cations in the gas phaseMass Spectrometry Reviews, 1992